Trump Announces 'TrumpRx' Plan After Pfizer 'Most-Favored-Nation' Deal Extracted via Tariff Threats

Trump announced the planned "TrumpRx" website the same day he disclosed that Pfizer had agreed to Most-Favored-Nation Medicaid pricing — the first major manufacturer to bend after months of public tariff threats ("Nobody wanted to play that game," Trump said of the holdouts). The site was pitched as a direct-to-consumer destination where Americans would "know" they were getting the best price, targeted for early 2026. The announcement landed one day after PhRMA, the pharmaceutical industry lobby, unveiled its own direct-to-consumer discount site — setting a government-branded competitor against the industry plan. The tariff-exemption-for-price-cuts exchange established the coercive template for every subsequent MFN deal: manufacturers faced tariff escalation on pharmaceutical imports unless they cut US prices, with the exemptions themselves becoming the bargaining chip.